Home / Countries / Estonia / HIV medicines

Estonia · availability and reimbursement

HIV medicines in Estonia

Of 26 verified HIV medicine records for Estonia, 21 are available and reimbursed (81%), 3 are available but not reimbursed and 2 are not available. 16 further records are still under review.

81% of verified records reimbursed

Last checked 02/11/2026 · This is information only, not advice or a recommendation.

Medicines by status

Available and reimbursed 21

Biktarvy, Celsentri, Delstrigo, Descovy, Dovato, Edurant, Epivir, Generic TDF/FTC (Emtricitabine/Tenofovir DF), Genvoya, Intelence, Isentress, Juluca, Kaletra, Odefsey, Pifeltro, Prezista, Retrovir, Symtuza, Tivicay, Triumeq, Truvada

Available, not reimbursed 3

Rukobia, Sunlenca, Vocabria

Not available 2

Generic TLD (Tenofovir/Lamivudine/Dolutegravir), Generic TLE (Tenofovir/Lamivudine/Efavirenz)

Under review 16

Apretude, Emtricitabine / Rilpivirine / Tenofovir Alafenamide Viatris, Emtricitabine / Tenofovir alafenamide Viatris, Emtriva, Eviplera, Evotaz, Kivexa, Norvir, Rekambys, Reyataz, Rezolsta, Stribild, Viread, Vocabria / Rekambys, Yeytuo, Ziagen

See every medicine with its source →

More about Estonia

PrEPDoxyPEPSexuality educationAbortion and contraceptionMigrant healthcareFull Estonia profile

Neighbouring countries

Russian FederationLatviaLithuaniaBelarus

Open the interactive map

Based on public, cited sources and SHAPE's review. Rules and prices change, so please confirm with the national authority or a professional. Found an error? Tell us.